Rubella medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(2 intermediate revisions by 2 users not shown)
Line 15: Line 15:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}


[[Category:Teratogens]]
[[Category:Teratogens]]
Line 20: Line 23:
[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Togaviruses]]
[[Category:Togaviruses]]
[[Category:Emergency medicine]]
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Emergency medicine]]
[[Category:Dermatology]]
[[Category:Primary care]]
 
{{WH}}
{{WS}}

Latest revision as of 00:04, 30 July 2020

Rubella Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Rubella from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Rubella medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rubella medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rubella medical therapy

CDC on Rubella medical therapy

Rubella medical therapy in the news

Blogs on Rubella medical therapy

Directions to Hospitals Treating Rubella

Risk calculators and risk factors for Rubella medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]

Overview

There is no specific antiviral therapy for rubella infection. Symptomatic therapy and reporting of the infection to the local disease control agencies is recommended.

Treatment

  • There is no specific antiviral therapy for rubella infection.
  • Health care providers should perform the following when diagnosis of rubella is suspected:
    • Consider rubella in unvaccinated patients with febrile rash illness and other rubella symptoms, especially if the person recently traveled internationally or was exposed to a person with febrile rash illness.
    • Promptly isolate people suspected to have rubella and report them to the local health department.
    • Collect throat (best source), nasal, or urine specimens for viral detection by polymerase chain reaction (PCR) testing and molecular typing, and blood for serologic testing.

References

Template:WH Template:WS